Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a retrospective analysis by Milki, Amin A & Jun, Sunny H
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
BMC Pregnancy and Childbirth
Open Access Research article
Ectopic pregnancy rates with day 3 versus day 5 embryo transfer: a 
retrospective analysis
Amin A Milki* and Sunny H Jun
Address: Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, U.S.A
Email: Amin A Milki* - milki4@aol.com; Sunny H Jun - shjun@stanford.edu
* Corresponding author    
BlastocystEctopic pregnancyEmbryo transferIVF
Abstract
Background: Blastocyst transfer may theoretically decrease the incidence of ectopic pregnancy
following IVF-ET in view of the decreased uterine contractility reported on day 5. The purpose of
our study is to specifically compare the tubal pregnancy rates between day 3 and day 5 transfers.
Methods: A retrospective analysis of all clinical pregnancies conceived in our IVF program since
1998 was performed. The ectopic pregnancy rates were compared for day 3 and day 5 transfers.
Results: There were 623 clinical pregnancies resulting from day 3 transfers of which 22 were
ectopic (3.5%). In day 5 transfers, there were 13 ectopic pregnancies out of 333 clinical pregnancies
(3.9%). The difference between these rates is not statistically significant (P = 0.8).
Conclusions:  Our data suggests that the ectopic pregnancy rate is not reduced following
blastocyst transfer compared to day 3 transfer. While there may be several benefits to extended
culture in IVF, the decision to offer blastocyst transfer should be made independently from the
issue of ectopic pregnancy risk.
Background
Ectopic pregnancy has been reported to occur in approxi-
mately 2–5% of all clinical pregnancies after IVF-ET [1–4].
Although the direct injection of transfer media with
embryos into the fallopian tubes may account for the
development of tubal pregnancies after IVF, migration of
embryos to the tubes by reflux expulsion from uterine
contractions has been proposed as another possible expla-
nation. [3,5]
Uterine junctional zone activity has been shown to
decrease with increasing time after oocyte retrieval. [6].
When comparing day 2 to day 3 transfers, Lesny et al. [3]
showed a trend for a lower ectopic pregnancy rate in the
day 3 transfer group which they attributed to the
decreased uterine contractility further along in the luteal
phase. Fanchin et al. [7] reported a significant reduction in
retrograde uterine contractility, from the cervix to the fun-
dus, 7 days after hCG administration compared to both 4
days after and the day of hCG injection. These findings
suggest that blastocyst transfer should be associated with
a lower incidence of ectopic pregnancy compared to cleav-
age stage transfer. The larger diameter of the blastocyst
was proposed as an additional factor in reducing the rate
of tubal pregnancies after day 5 transfer. [8]
Despite these theoretical considerations, large series that
specifically compare the incidence of ectopic pregnancy
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with blastocyst versus cleavage stage transfers are lacking
in the literature. The purpose of our study is to shed light
on this issue by examining the ectopic pregnancy rates
after day 3 transfer compared to day 5 transfer in our pro-
gram over a 5 year period.
Methods
We reviewed all clinical pregnancies conceived in our IVF
program since 1998 when blastocyst transfer was intro-
duced to our center. The incidence of ectopic pregnancy
was compared between day 3 and day 5 transfers in the
same time period.
The controlled ovarian hyperstimulation protocol con-
sisted of pretreatment with oral contraceptive pills with
overlapping GnRH agonist down-regulation followed by
FSH/hHMG and hCG, microdose flare or antagonist pro-
tocols. Oocytes were inseminated conventionally or by
ICSI 3–4 hours after retrieval. Embryos were cultured in
groups under mineral oil in 150 µL droplets of P1
medium (Irvine Scientific, Santa Ana, CA, USA) with 10%
Serum Substitute Supplement (SSS) at 37 degrees Celsius
in a 5% O2, 5% CO2 and 90% N2 environment for 72
hours. For the blastocyst transfer group, the embryos were
moved on day 3 into Blastocyst medium (Irvine Scien-
tific) with 10% SSS and cultured for 48 hours before trans-
fer. Additional blastocysts were cryopreserved on day 5 or
day 6.
All transfers were performed using a Tefcat catheter (Cook
Ob/Gyn, Spencer, IN, USA) 1 to 1.5 cm short of the fun-
dus under transabdominal ultrasound guidance. The
transfer volume was 20–30 µL.
Clinical pregnancies were defined by seeing a gestational
sac on transvaginal ultrasound or by diagnosing an
ectopic pregnancy. Ectopic pregnancies were diagnosed by
ultrasound or by laparoscopic visualization of a gesta-
tional sac in the fallopian tube or by the absence of an
intrauterine gestational sac and rising βhCG levels follow-
ing the failure of suction D&C to reveal products of
conception.
The rate of ectopic pregnancies for day 3 and day 5 trans-
fers was compared. Chi-square testing was used for statis-
tical analysis. Significance was set at P < 0.05. Institutional
review board approval was obtained for chart review.
Results
There were 623 clinical pregnancies resulting from day 3
transfer of which 22 were ectopic (3.5%). In day 5 trans-
fers, there were 13 ectopic pregnancies out of 333 clinical
pregnancies (3.9%). The difference between these rates is
not statistically significant (P = 0.8). Of the 22 ectopic
pregnancies with day 3 transfer, 9 were in patients with
tubal disease compared to 5 out of the 13 ectopic preg-
nancies with day 5 transfer (P = 0.9). More importantly,
the incidence of tubal disease was similar in the day 3
transfer and the day 5 transfer groups, 22 and 24%,
respectively (P = 0.4). The mean ages were 37.7(± 4.9)
years in the day 3 group and 35.3 (± 4.7) years in the day
5 group (P < 0.01). The mean BMI was similar in both
groups. (Table 1)
In our program, we primarily perform cryopreservation at
the blastocyst stage. [9] Accordingly, the day 5 transfer
group includes the vast majority of the thaw embryo
transfers. When these pregnancies are excluded and only
fresh transfers are considered, the ectopic pregnancy rate
remains similar for day 3 and day 5 at 3.5% (22/615) and
3.3% (9/271), respectively. (P = 0.8)
Discussion
Studies that showed decreased uterine contractility further
along in the luteal phase [6,7] would imply that the
ectopic pregnancy rates should be reduced after a day 5
transfer compared to a cleavage stage transfer. It has also
been postulated that the larger size of the blastocyst may
decrease the chances of the day 5 embryo from migrating
to the fallopian tube. [8] Despite these theoretical
mechanisms which suggest that day 5 transfer is associ-
ated with a lowered ectopic pregnancy risk, our study,
which examined close to a thousand pregnancies, failed to
show such a trend. It is possible that when a blastocyst is
transferred, it does indeed have a lower probability of
entering the fallopian tube. However, the blastocyst that
does reach the tube may have a higher tendency to
implant there while the day 3 embryo has 2 additional
days, compared to the day 5 embryo, to migrate back into
the uterine cavity.
Table 1: Comparison of ectopic pregnancy rates in day 3 versus day 5 embryo transfers
Day 3-ET Day 5 Transfer P-value
EctopicPregnancy/Clinical Pregnancy 22/623 (3.5%) 13/333 (3.9%) NS
Ectopic Pregnancy/Clinical Pregnancy (Excluding 
Frozen Embryo transfers)
22/615 (3.5%) 9/271(3.3%) NS
Mean Age (yrs) 37.7 ± 4.9 35.3 ± 4.7 <0.01
Mean BMI 22.9 ± 3.4 23.2 ± 3.5 NS
%Tubal Disease 22% 24% NSBMC Pregnancy and Childbirth 2003, 3 http://www.biomedcentral.com/1471-2393/3/7
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A potential source of bias in our study is the fact that blas-
tocyst transfer was offered to patients with more than 3
eight cell embryos on day 3 which is likely to occur in
patients with a higher number of oocytes and higher
estrogen levels. Specific data on oocyte number is not
available for our study, and we do not routinely measure
estradiol levels in our program. However, when specifi-
cally analyzed in previous studies in the literature [1,2],
these parameters were not found to affect the incidence of
tubal pregnancy. Although the patients in the blastocyst
transfer group were on the average 2 years younger than
those in the day 3 group, it is unlikely that this small dif-
ference could have had an impact on increasing the
ectopic pregnancy rate in the day 5 group. If anything, the
rate of ectopic pregnancy has been reported to increase
with age [10]. Another confounding factor could be the
prevalence of tubal disease in the two patient populations
studied, as tubal pathology has been shown to be a major
risk factor for the development of an ectopic pregnancy
with IVF [11,12] The incidence of tubal disease is unlikely
to be a source of bias in our study since it was similar in
our day 3 and day 5 transfer groups.
Although a comparison of the incidence of ectopic preg-
nancy between cleavage stage transfer and blastocyst
transfer has not been the specific subject of any prior study
in the literature, information on this issue can be found in
a report by Marek et al. [13] In their study, the authors
compared the pregnancy rates in their program when they
switched from day 3 to day 5 transfer for all patients. The
ectopic pregnancy rates can be extrapolated from their
tabulated data as being 1% (2/199) with day 3 and 1.3%
(2/159) with day 5 transfers. The findings of this smaller
series confirm the absence of a decrease in ectopic rates
after blastocyst transfer.
The literature contains 2 additional studies that inciden-
tally report data allowing the computation of the ectopic
pregnancy rate with blastocyst transfer without any infor-
mation on day 3 transfers. In one study, Pantos et al. [14]
examined the influence of age on the pregnancy rate after
blastocyst transfer and mentioned 4 ectopic pregnancies
out of a total of 99 pregnancies (4%). In the other study,
Tarlatzis et al. [15] looked at monozygotic twinning with
blastocyst transfer after ICSI and conventional IVF and
noted an ectopic pregnancy rate of 2 out of 48 pregnancies
(4.2%). Although the purpose of these studies was not
related to the issue of ectopic pregnancy and they lacked
day 3 controls, the rates of about 4% are in line with what
has been reported with day 3 transfers and suggest that
blastocyst transfer does not reduce the likelihood of tubal
pregnancy.
Conclusion
We believe that blastocyst transfer is a valuable tool that
has enabled IVF programs to more accurately select the
embryos with the highest potential for implantation [16–
18] allowing for a good pregnancy rate while avoiding
high order multiple gestations [19,20]. In our program,
we offer blastocyst transfer to patients of any age [21] if
they have more than 3 eight cell embryos. Although some
authors have advocated routine blastocyst transfer in all
patients [13,22], offering extended culture when there are
no eight cell embryos on day 3 has been reported to be
detrimental [23]. We suggest that programs establish the
criteria that work for them for offering blastocyst culture
and transfer. However, based on the results of this study,
the presence of risk factors favoring ectopic pregnancy
should not be taken into account in the decision making
for choosing to transfer on day 3 or day 5.
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